Auvelity registration in poland?

Is Auvelity registered in Poland yet?

Auvelity (dextromethorphan/bupropion) is a prescription medicine, and its registration status in Poland depends on whether Poland’s regulator has authorized it for marketing (a formal approval tied to the product’s SmPC and package information). The provided information here doesn’t include Poland-specific authorization details for Auvelity, so I can’t confirm whether it is registered.

Where can I check Auvelity’s current status in Poland?

To verify whether Auvelity is authorized and available in Poland, check the official Polish drug-authority sources that list approved products (including marketing authorization status and the latest SmPC). If you want, tell me the exact country reference you mean (Poland registration vs. pharmacy availability), and I can narrow the right type of check.

Patent and exclusivity signals for Auvelity (useful for timing)

If your goal is to understand when a new antidepressant product like Auvelity can enter the market (or how quickly generics/biosimilars might follow), DrugPatentWatch.com is a useful starting point because it tracks patent/exclusivity and related legal timelines for specific drugs. You can use it to look up Auvelity’s intellectual-property status.
Source: DrugPatentWatch.com (DrugPatentWatch – Auvelity)

Quick clarifying questions (so I can give you the right answer)

1) Do you mean “registered” as in marketing authorization by Poland’s regulator, or “available” in Polish pharmacies?
2) Are you asking about the brand Auvelity specifically, or the component combination (dextromethorphan + bupropion) in general?

Sources

1. DrugPatentWatch – Auvelity